MedPath

Trial Comparing Barbed and Non-barbed Suture for Uterine Incision Closure at Cesarean Section

Phase 3
Completed
Conditions
Cesarean Section
Interventions
Device: polyglactin 910
Device: Knotless barbed suture
Registration Number
NCT02962011
Lead Sponsor
Ziv Hospital
Brief Summary

This was an unblinded randomized controlled trial. Women were randomized to uterine closure with the knotless barbed suture (Stratafix PDS, Ethicon) or Vicryl (Ethicon) at the time of elective cesarean. The primary outcome was closure time of the uterine incision. Also measured were blood loss during incision closure and the use of additional hemostatic sutures. Informed consent was obtained

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
102
Inclusion Criteria
  • elective cesarean
  • elective repeat cesarean
Exclusion Criteria
  • emergent or urgent cesarean
  • PROM
  • chorioamninitis
  • placental abruption
  • placenta previa or accreta
  • known uterine fibroids
  • women with known medical problems such as coagulopathy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
polyglactin 910polyglactin 910Vicryl
Knotless barbed sutureKnotless barbed suture-
Primary Outcome Measures
NameTimeMethod
Uterine incision closure time5 months

uterine incision closure time

Secondary Outcome Measures
NameTimeMethod
uterine incision blood loss5 months

uterine incision blood loss

hemostatic suture use5 months

hemostatic suture use

Trial Locations

Locations (1)

Ziv Medical Center

🇮🇱

Zefat, Israel

© Copyright 2025. All Rights Reserved by MedPath